View drug registration information details.


ItemsRegistration information
ID1642
No1642
Brand NameCAPANIB
IngredientsCAPMATINIB 200 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 56'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsUsed for the treatment of adult patients with metastatic, non-small cell lung cancer (NSCLC) whose tumors have tested positive for a mutation that leads to MET exon 14 skipping
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionREDDISH BROWN TABLET
Note
License OwnerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
ManufacturerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No11 L 0934/22
FDD Registration Date06-DEC-2022
Expiry Date05-DEC-2025

Back to drug list